References
- Rapold H. J., Wu Z. M., Stassen T., Van de Werf F., Collen D. Comparison of intravenous bolus injection or continuous infusion of recombinant single chain urokinase-type plasminogen activator(saruplase) for thrombolysis. A canine model of combined coronary arterial and femoral venous thrombosis. Blood. 1990; 76: 1558–1563
- Tait J. F., Cerqueira M. D., De Whurst T. A., Fujikawa K., Ritchie J. L., Stratton JR. Evaluation of annexin V as a platelet-directed thrombus targeting agent. Thromb Res. 1994; 75: 491–501
- Takiguchi Y., Hirata Y., Wada K., Nakashima M. Arterial thrombosis model with photochemical reaction in guinea-pig and its property. Thromb Res. 1992; 67: 435–445
- Doutremepuich C., Aguejouf O., Pintigny D., Sertillanges N., De Seze O. Thrombogenic properties of ultra-low-dose of acetylsalicylic acid in a vessel model of laser-induced thrombus formation. Thromb Res. 1994; 76: 225–229
- Haskel E. J., Torr S. R., Day K. C., Palmier M. O., Wun T. C., Sobel B. E., Abendschein DR. Prevention of arterial reocclusion after thrombolysis with recombinant lipoprotein-associated coagulation inhibitor. Circulation 1991; 84: 821–827
- Samama C. M., Mazoyer E., Bruneval P., Ciostek P., Bonnin P., Bonneau M., Roussi J., Bailliart O., Pignaud G., Viars P., Caen J. P., Drouet LO. Aprotinin could promote arterial thrombosis in pigs: A prospective randomized, blind study. Thromb Haemost. 1994; 71: 663–669